Last Update 08 Dec 25
Fair value Increased 2.23%BWXT: Expanding Nuclear Defense And Enrichment Contracts Will Drive Future Momentum
Analysts have nudged our fair value estimate for BWX Technologies higher to approximately $221 from about $216, citing a series of Street price target increases that reflect growing conviction in the company’s unique positioning across nuclear defense and commercial power markets.
Analyst Commentary
Bullish analysts highlight that the reset in targets is grounded in rising conviction that BWX can convert its strong backlog and program visibility into sustained double digit earnings growth, supporting a higher multiple versus traditional defense peers.
They also point to the company’s differentiated position across nuclear components and fuel for both defense and commercial applications, arguing that this combination provides a durable growth runway and reduces reliance on any single program or end market.
At the same time, recent target hikes still embed a degree of conservatism around execution and regulatory risk in nuclear power, which leaves room for upside revisions if project timelines and cost performance remain favorable.
Bullish Takeaways
- Bullish analysts see structural tailwinds from increasing global interest in nuclear power generation, which supports sustained top line growth and justifies higher long term valuation assumptions.
- Exposure to large, multiyear nuclear defense programs is viewed as providing sticky, visibility rich revenue that underpins cash flow forecasts and supports premium multiples.
- The merchant supply opportunity in commercial nuclear fuel and components is framed as incremental upside, giving BWX leverage to any acceleration in reactor restarts or new build activity.
- Coverage initiations and target increases around the $170 to $205 range suggest growing confidence that management can execute on both existing programs and incremental growth initiatives without material margin erosion.
Bearish Takeaways
- Bearish analysts maintain more restrained ratings despite higher targets, noting that near term valuation already discounts a robust growth trajectory, leaving less room for execution missteps.
- There is caution that broader defense budget uncertainty, including potential government funding disruptions, could complicate timing for awards and weigh on future guidance.
- Some also flag that BWX is not immune to supply chain pressures affecting aerospace and defense, which could introduce cost or delivery risk and cap near term margin expansion.
- Compared with more diversified industrial peers, BWX’s concentrated focus in nuclear related projects is seen as adding regulatory and policy risk that could limit multiple expansion in downside scenarios.
What's in the News
- BWX secured a 10 year, $1.6 billion contract with the U.S. National Nuclear Security Administration to build and operate a new high purity depleted uranium manufacturing plant in Jonesborough, Tennessee, expected to produce up to 300 metric tons annually and create about 175 skilled jobs (company announcement).
- The company won a separate 10 year, $1.5 billion NNSA contract to design, build and operate the Domestic Uranium Enrichment Centrifuge Experiment pilot plant in Erwin, Tennessee, supporting development of a fully domestic uranium enrichment capability for defense missions (company announcement; Bloomberg).
- BWX will serve as Owner's Engineer in a multi party consortium for Bulgaria's planned Kozloduy Units 7 and 8 AP1000 reactors, on a contract worth hundreds of millions of euros over roughly a decade, extending its international nuclear services footprint (company announcement).
- BWX raised its 2025 revenue outlook to more than $3.1 billion and confirmed completion of its latest share repurchase tranche, citing confidence in its long term growth strategy and capital allocation approach (company guidance and buyback update).
- TRISO fuel produced by BWX has arrived at Idaho National Laboratory for the Project Pele microreactor prototype, marking a key milestone in demonstrating transportable, 1.5 megawatt advanced microreactor technology for U.S. defense applications (company announcement).
Valuation Changes
- The fair value estimate has risen slightly to approximately $221 from about $216, reflecting marginally higher long-term expectations.
- The discount rate has increased modestly to about 7.70% from roughly 7.66%, implying a slightly higher required return on equity.
- The revenue growth assumption is essentially unchanged at around 13.37%, indicating stable expectations for top-line expansion.
- The net profit margin forecast remains effectively flat at roughly 10.9%, signaling no material change in long-run profitability assumptions.
- The future P/E multiple has risen slightly to about 51.7x from roughly 50.5x, indicating a small uplift in the valuation applied to forward earnings.
Key Takeaways
- Strong defense and nuclear energy demand, government contracts, and new technologies are driving recurring revenue growth and earnings stability.
- Expansion into microreactors, advanced fuels, and services increases high-margin opportunities and positions the company for further market and margin growth.
- Heavy dependence on government contracts, volatile commercial demand, margin pressure, and workforce and supply chain risks threaten consistent profitability and future revenue growth.
Catalysts
About BWX Technologies- Manufactures and sells nuclear components in the United States, Canada, and internationally.
- Record $6 billion backlog (+70% YoY) and 23% quarter-over-quarter growth, driven by multi-year defense contracts, rapidly expanding opportunity pipeline, and accelerating nuclear energy/medical demand signal strong visibility into future revenue growth and earnings stability.
- Two+ major Navy submarine/carrier propulsion agreements (worth $4.7B+) secured in the past 8 months, backed by sustained government support for defense modernization and nuclear triad reinforcement, support the outlook for recurring/compounding revenue and stable margins as the U.S. moves forward with its long-term shipbuilding plans.
- Accelerating activity in advanced commercial nuclear (CANDU life extensions, international new builds, AP1000, SMRs) and acceptance of first U.S. SMR construction permit have increased BWXT's addressable market, positioning the company to benefit from the global energy transition and policy incentives-potentially driving significant, high-margin backlog and top-line growth.
- Expansion into microreactors (Pele, potential DoD-wide procurement) and advanced nuclear fuels (TRISO contracts, defense enrichment, depleted uranium production) aligns with government decarbonization targets and national security priorities, creating new, higher-margin revenue streams and supporting future EBITDA margin expansion.
- Recent acquisition of Kinectrics significantly broadens life-of-plant and nuclear services portfolio, deepening customer relationships and increasing recurring service revenue, which, alongside ongoing medical isotopes growth (20%+ YoY), underpins both margin durability and organic revenue compounding.
BWX Technologies Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming BWX Technologies's revenue will grow by 11.1% annually over the next 3 years.
- Analysts assume that profit margins will increase from 10.3% today to 12.6% in 3 years time.
- Analysts expect earnings to reach $494.7 million (and earnings per share of $5.4) by about September 2028, up from $294.4 million today. However, there is some disagreement amongst the analysts with the more bearish ones expecting earnings as low as $388 million.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 41.9x on those 2028 earnings, down from 50.4x today. This future PE is greater than the current PE for the US Aerospace & Defense industry at 34.4x.
- Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 7.83%, as per the Simply Wall St company report.
BWX Technologies Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- Heavy reliance on long-term U.S. government and Navy contracts could expose BWX Technologies to material revenue and earnings volatility if there are future changes in defense budgets, political priorities, or procurement cycles, especially as major new awards now secure work for up to 8 years, making the backlog sensitive to shifts at contract renewal time.
- Organic revenue in commercial operations declined despite overall segment growth being driven by acquisitions, suggesting that organic demand for core civil nuclear services can be lumpy and potentially vulnerable to timing of outages, regulatory processes, or shifting utility spending patterns, which could impact future revenue growth.
- Margin pressure exists in commercial operations, with adjusted EBITDA margins down year-over-year due to unfavorable business mix, lower field services activity, and increased growth investments, indicating that higher capital intensity and fluctuating work mix may compress net margins in the future, particularly if growth investments do not yield expected returns.
- Continued dependence on a specialized workforce, with the potential for talent retention or aging workforce issues, presents long-term risks to project delivery, cost control, and sustaining technical leadership, which could erode profitability and delay or jeopardize the execution of high-value nuclear and defense contracts.
- While current supply chain and critical mineral pricing issues (e.g., zirconium) have stabilized and are largely passed through to customers, heightened regulatory, environmental, or commodity risks-such as more stringent nuclear regulations or new critical mineral shortages-could increase compliance costs and operational complexity, thereby negatively impacting long-term net margins.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of $181.5 for BWX Technologies based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $250.0, and the most bearish reporting a price target of just $120.0.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $3.9 billion, earnings will come to $494.7 million, and it would be trading on a PE ratio of 41.9x, assuming you use a discount rate of 7.8%.
- Given the current share price of $162.23, the analyst price target of $181.5 is 10.6% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on BWX Technologies?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.



